0001209191-13-037588.txt : 20130723
0001209191-13-037588.hdr.sgml : 20130723
20130723171032
ACCESSION NUMBER: 0001209191-13-037588
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130722
FILED AS OF DATE: 20130723
DATE AS OF CHANGE: 20130723
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trius Therapeutics Inc
CENTRAL INDEX KEY: 0001356857
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201320630
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DR SUITE 105
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-452-0370
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DR SUITE 105
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Finn John
CENTRAL INDEX KEY: 0001479788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34828
FILM NUMBER: 13981907
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE, SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-07-22
0
0001356857
Trius Therapeutics Inc
TSRX
0001479788
Finn John
C/O TRIUS THERAPEUTICS, INC.
6310 NANCY RIDGE DR, # 105
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
2013-07-22
4
S
0
1000
12.10
D
166860
I
By the John and Debbie Finn Trust
Common Stock
2151
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012
/s/ Michael Morneau, Attorney-in-Fact
2013-07-23